{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T18:00:52Z","timestamp":1791655252608,"version":"4.3.4"},"reference-count":74,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Drug Policies Department"},{"name":"Presidency of the Council of Ministers, Italy"},{"DOI":"10.13039\/501100007109","name":"University of Ferrara","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007109","id-type":"DOI","asserted-by":"publisher"}]},{"name":"ICS Maugeri, Pavia, Italy"},{"name":"Italian Ministry of the University","award":["RBFR12LDOW"],"award-info":[{"award-number":["RBFR12LDOW"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2018,10]]},"DOI":"10.1016\/j.neuropharm.2018.08.017","type":"journal-article","created":{"date-parts":[[2018,8,27]],"date-time":"2018-08-27T22:50:49Z","timestamp":1535410249000},"page":"167-180","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":46,"special_numbering":"C","title":["Neurological, sensorimotor and cardiorespiratory alterations induced by methoxetamine, ketamine and phencyclidine in mice"],"prefix":"10.1016","volume":"141","author":[{"given":"Andrea","family":"Ossato","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabrine","family":"Bilel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adolfo","family":"Gregori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Talarico","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudio","family":"Trapella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosa Maria","family":"Gaudio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabio","family":"De-Giorgio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franco","family":"Tagliaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margherita","family":"Neri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liana","family":"Fattore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8751-2882","authenticated-orcid":false,"given":"Matteo","family":"Marti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuropharm.2018.08.017_bib1","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/0014-2999(93)90851-8","article-title":"Cardiorespiratory effects produced by blockade of excitatory amino acid receptors in cats","volume":"238","author":"Abrahams","year":"1993","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2018.08.017_bib2","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1111\/1556-4029.12594","article-title":"Fatal intoxication with methoxetamine","volume":"60","author":"Adamowicz","year":"2015","journal-title":"J. Forensic Sci."},{"key":"10.1016\/j.neuropharm.2018.08.017_bib3","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1159\/000166498","article-title":"Rhabdomyolysis with and without acute renal failure in patients with phencyclidine intoxication","volume":"1","author":"Akmal","year":"1981","journal-title":"Am. J. Nephrol."},{"key":"10.1016\/j.neuropharm.2018.08.017_bib4","first-page":"169","article-title":"Effects of barbiturates, phencyclidine, ketamine and analogs on cerebral circulation and cerebrovascular muscle","volume":"1","author":"Altura","year":"1984","journal-title":"Microcirc. Endothelium Lymphatics"},{"key":"10.1016\/j.neuropharm.2018.08.017_bib5","doi-asserted-by":"crossref","first-page":"856","DOI":"10.3109\/15563650.2015.1079325","article-title":"Phencyclidine analog use in Sweden--intoxication cases involving 3-MeO-PCP and 4-MeO-PCP from the STRIDA project","volume":"53","author":"B\u00e4ckberg","year":"2015","journal-title":"Clin. Toxicol."},{"key":"10.1016\/j.neuropharm.2018.08.017_bib7","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.neuropharm.2017.08.028","article-title":"Phencyclidine-like in vivo effects of methoxetamine in mice and rats","volume":"134","author":"Berquist","year":"2017","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2018.08.017_bib8","first-page":"1","article-title":"Involvement of the striatal medium spiny neurons of the direct pathway in the motor stimulant effects of phencyclidine","volume":"19","author":"Bonito-Oliva","year":"2016","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.neuropharm.2018.08.017_bib9","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.pbb.2015.03.007","article-title":"Methoxetamine, a ketamine derivative, produced conditioned place preference and was self-administered by rats: evidence of its abuse potential","volume":"133","author":"Botanas","year":"2015","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.neuropharm.2018.08.017_bib10","doi-asserted-by":"crossref","first-page":"3685","DOI":"10.1007\/s00213-016-4402-y","article-title":"Effect of the novel synthetic cannabinoids AKB48 and 5F-AKB48 on \u201ctetrad\u201d, sensorimotor, neurological and neurochemical responses in mice. In vitro and in vivo pharmacological studies","volume":"233","author":"Canazza","year":"2016","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.neuropharm.2018.08.017_bib11","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/j.pbb.2012.03.001","article-title":"Differential behavioral profiling of stimulant substances in the rat using the LABORAS\u2122 system","volume":"101","author":"Castagn\u00e9","year":"2012","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.neuropharm.2018.08.017_bib12","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/0014-2999(81)90086-8","article-title":"Acute and chronic phencyclidine effects on locomotor activity, stereotypy and ataxia in rats","volume":"73","author":"Castellani","year":"1981","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2018.08.017_bib13","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1097\/FBP.0000000000000221","article-title":"The ketamine analogue methoxetamine generalizes to ketamine discriminative stimulus in rats","volume":"27","author":"Chiamulera","year":"2016","journal-title":"Behav. Pharmacol."},{"key":"10.1016\/j.neuropharm.2018.08.017_bib14","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1002\/hup.2422","article-title":"Methoxetamine-related deaths in the UK: an overview","volume":"30","author":"Chiappini","year":"2015","journal-title":"Hum. Psychopharmacol."},{"key":"10.1016\/j.neuropharm.2018.08.017_bib15","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1016\/j.mehy.2012.07.002","article-title":"Methoxetamine: from drug of abuse to rapid-acting antidepressant","volume":"79","author":"Coppola","year":"2012","journal-title":"Med. Hypotheses"},{"key":"10.1016\/j.neuropharm.2018.08.017_bib16","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1002\/hup.1242","article-title":"Phenomenon of new drugs on the Internet: the case of ketamine derivative methoxetamine","volume":"27","author":"Corazza","year":"2012","journal-title":"Hum. Psychopharmacol."},{"key":"10.1016\/j.neuropharm.2018.08.017_bib17","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1111\/cns.12063","article-title":"From \u201cSpecial K\u201d to \u201cSpecial M\u201d: the evolution of the recreational use of ketamine and methoxetamine","volume":"19","author":"Corazza","year":"2013","journal-title":"CNS Neurosci. Ther."},{"key":"10.1016\/j.neuropharm.2018.08.017_bib18","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.7205\/MILMED-D-13-00470","article-title":"The ketamine analog methoxetamine: a new designer drug to threaten military readiness","volume":"179","author":"Craig","year":"2014","journal-title":"Mil. Med."},{"key":"10.1016\/j.neuropharm.2018.08.017_bib19","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/S0278-5846(97)00184-X","article-title":"Effects of phencyclidine (PCP) and (+)MK-801 on sensorimotor gating in CD-1 mice","volume":"22","author":"Curzon","year":"1998","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2018.08.017_bib20","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/0091-3057(94)90506-1","article-title":"Glutamate antagonists have different effects on spontaneous locomotor activity in rats","volume":"48","author":"Danysz","year":"1994","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.neuropharm.2018.08.017_bib21","first-page":"A7358","article-title":"A patient in a methoxetamine-induced dissociative psychosis","volume":"158","author":"de Jong","year":"2014","journal-title":"Ned. Tijdschr. Geneeskd."},{"key":"10.1016\/j.neuropharm.2018.08.017_bib22","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1111\/1556-4029.12407","article-title":"A polydrug intoxication involving methoxetamine in a drugs and driving case","volume":"59","author":"Elian","year":"2014","journal-title":"J. Forensic Sci."},{"key":"10.1016\/j.neuropharm.2018.08.017_bib23","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/0165-0173(94)00014-G","article-title":"The N-methyl-D-aspartate antagonists phencyclidine, ketamine and dizocilpine as both behavioral and anatomical models of the dementias","volume":"20","author":"Ellison","year":"1995","journal-title":"Brain Res. Brain Res. Rev."},{"key":"10.1016\/j.neuropharm.2018.08.017_bib24","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1002\/hup.2560","article-title":"1-cyclohexyl-x-methoxybenzene derivatives, novel psychoactive substances seized on the internet market. Synthesis and in vivo pharmacological studies in mice","volume":"32","author":"Fantinati","year":"2017","journal-title":"Hum. Psychopharmacol."},{"key":"10.1016\/j.neuropharm.2018.08.017_bib25","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1093\/jat\/bkw054","article-title":"An impaired driver found to be under the influence of methoxetamine","volume":"40","author":"Fassette","year":"2016","journal-title":"J. Anal. Toxicol."},{"key":"10.1016\/j.neuropharm.2018.08.017_bib26","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/s002130100811","article-title":"Pharmacological studies of prepulse inhibition models of sensorimotor gating deficits in schizophrenia: a decade in review","volume":"156","author":"Geyer","year":"2001","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.neuropharm.2018.08.017_bib27","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1520\/JFS14742J","article-title":"Ketamine in non-hospital and hospital deaths in New York City","volume":"45","author":"Gill","year":"2000","journal-title":"J. Forensic Sci."},{"key":"10.1016\/j.neuropharm.2018.08.017_bib28","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1007\/s00216-015-9221-1","article-title":"Salting-out-assisted liquid-liquid extraction as a suitable approach for determination of methoxetamine in large sets of tissue samples","volume":"408","author":"Hajkova","year":"2016","journal-title":"Anal. Bioanal. Chem."},{"key":"10.1016\/j.neuropharm.2018.08.017_bib29","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1007\/s00213-016-4203-3","article-title":"The novel ketamine analog methoxetamine produces dissociative-like behavioral effects in rodents","volume":"233","author":"Halberstadt","year":"2016","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.neuropharm.2018.08.017_bib30","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.taap.2013.04.039","article-title":"Safety pharmacology--current and emerging concepts","volume":"273","author":"Hamdam","year":"2013","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.neuropharm.2018.08.017_bib31","doi-asserted-by":"crossref","first-page":"446","DOI":"10.3109\/15563650.2015.1033630","article-title":"Intoxications by the dissociative new psychoactive substances diphenidine and methoxphenidine","volume":"53","author":"Helander","year":"2015","journal-title":"Clin. Toxicol."},{"key":"10.1016\/j.neuropharm.2018.08.017_bib32","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/s11916-003-0009-1","article-title":"N-methyl-D-aspartate-enhanced analgesia","volume":"7","author":"Hewitt","year":"2003","journal-title":"Curr. Pain Headache Rep."},{"key":"10.1016\/j.neuropharm.2018.08.017_bib33","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.drugalcdep.2014.11.033","article-title":"Monitoring new psychoactive substances (NPS) in The Netherlands: data from the drug market and the Poisons Information Centre","volume":"147","author":"Hondebrink","year":"2015","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.neuropharm.2018.08.017_bib34","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.neuropharm.2017.04.035","article-title":"Neuropharmacological characterization of the new psychoactive substance methoxetamine","volume":"123","author":"Hondebrink","year":"2017","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2018.08.017_bib35","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.brainresbull.2016.05.002","article-title":"Detailed pharmacological evaluation of methoxetamine (MXE), a novel psychoactive ketamine analogue-Behavioural, pharmacokinetic and metabolic studies in the Wistar rat","volume":"126","author":"Horsley","year":"2016","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.neuropharm.2018.08.017_bib36","series-title":"US Food and Drug Administration Guidance for Industry: Safety Pharmacology Studies for Human Pharmaceuticals (S7A)","author":"ICH, S7A","year":"2001"},{"key":"10.1016\/j.neuropharm.2018.08.017_bib37","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1093\/jat\/bku052","article-title":"Analytical findings of an acute intoxication after inhalation of methoxetamine","volume":"38","author":"Imbert","year":"2014","journal-title":"J. Anal. Toxicol."},{"key":"10.1016\/j.neuropharm.2018.08.017_bib38","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/j.brainresbull.2006.01.010","article-title":"Dose-response characteristics of ketamine effect on locomotion, cognitive function and central neuronal activity","volume":"69","author":"Imre","year":"2006","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.neuropharm.2018.08.017_bib39","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1007\/BF00401402","article-title":"Comprehensive observational assessment: Ia. A systematic, quantitative procedure for assessing the behavioral and physiologic state of the mouse","volume":"13","author":"Irwin","year":"1968","journal-title":"Psychopharmacologia"},{"key":"10.1016\/j.neuropharm.2018.08.017_bib40","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1176\/ajp.148.10.1301","article-title":"Recent advances in the phencyclidine model of schizophrenia","volume":"148","author":"Javitt","year":"1991","journal-title":"Am. J. Psychiatr."},{"key":"10.1016\/j.neuropharm.2018.08.017_bib41","doi-asserted-by":"crossref","first-page":"7107","DOI":"10.3402\/ehtj.v4i0.7107","article-title":"The epidemiology and patterns of acute and chronic toxicity associated with recreational ketamine use","volume":"4","author":"Kalsi","year":"2011","journal-title":"Emerg. Health Threats J."},{"key":"10.1016\/j.neuropharm.2018.08.017_bib42","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/0091-3057(81)90330-0","article-title":"Phencyclidine and behavior: I. Sensory-motor function, activity level, taste aversion and water intake","volume":"15","author":"Kesner","year":"1981","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.neuropharm.2018.08.017_bib43","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1080\/02791072.2013.803647","article-title":"Methoxetamine (MXE)--a phenomenological study of experiences induced by a \u201clegal high\u201d from the internet","volume":"45","author":"Kjellgren","year":"2013","journal-title":"J. Psychoact. Drugs"},{"key":"10.1016\/j.neuropharm.2018.08.017_bib44","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/S0301-0082(98)00098-7","article-title":"The neurobiology of startle","volume":"59","author":"Koch","year":"1999","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.neuropharm.2018.08.017_bib45","doi-asserted-by":"crossref","first-page":"36680","DOI":"10.1038\/srep36680","article-title":"The role of P2X7 receptors in a rodent PCP-induced schizophrenia model","volume":"6","author":"Kov\u00e1nyi","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.neuropharm.2018.08.017_bib46","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1038\/nrn2153","article-title":"NMDA receptor trafficking in synaptic plasticity and neuropsychiatric disorders","volume":"8","author":"Lau","year":"2007","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.neuropharm.2018.08.017_bib47","first-page":"671","article-title":"Acute methoxetamine intoxication--a case report with serum and urine concentrations","volume":"70","author":"\u0141ukasik-G\u0142ebocka","year":"2013","journal-title":"Przegl. Lek."},{"key":"10.1016\/j.neuropharm.2018.08.017_bib48","first-page":"1","article-title":"Ketamine: 50 years of modulating the mind","volume":"29","author":"Li","year":"2016","journal-title":"Front. Hum. Neurosci."},{"key":"10.1016\/j.neuropharm.2018.08.017_bib49","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1097\/00003246-198309000-00012","article-title":"Sequential cardiorespiratory patterns of anesthetic induction with ketamine in critically ill patients","volume":"11","author":"Lippmann","year":"1983","journal-title":"Crit. Care Med."},{"key":"10.1016\/j.neuropharm.2018.08.017_bib50","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/0014-2999(91)90253-M","article-title":"Effects of NMDA receptor ligands on sensorimotor gating in the rat","volume":"202","author":"Mansbach","year":"1991","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2018.08.017_bib51","series-title":"Proceeding of V International Conference on Novel Psychoactive Substances (NPS)","article-title":"Motor, sensorimotor and cardio-respiratory changes induced by PCP, ketamine and methoxetamine in mice","author":"Marti","year":"2017"},{"key":"10.1016\/j.neuropharm.2018.08.017_bib53","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/0014-2999(84)90201-2","article-title":"Effects of phencyclidine (PCP) on cardiorespiratory functions in the rhesus monkey","volume":"103","author":"Matsuzaki","year":"1984","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2018.08.017_bib54","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1002\/dta.1620","article-title":"From PCP to MXE: a comprehensive review of the non-medical use of dissociative drugs","volume":"6","author":"Morris","year":"2014","journal-title":"Drug Test. Anal."},{"key":"10.1016\/j.neuropharm.2018.08.017_bib55","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.neuint.2007.06.019","article-title":"Phencyclidine animal models of schizophrenia: approaches from abnormality of glutamatergic neurotransmission and neurodevelopment","volume":"51","author":"Mouri","year":"2007","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.neuropharm.2018.08.017_bib56","doi-asserted-by":"crossref","first-page":"2241","DOI":"10.1007\/s00213-016-4275-0","article-title":"The ketamine-like compound methoxetamine substitutes for ketamine in the self-administration paradigm and enhances mesolimbic dopaminergic transmission","volume":"233","author":"Mutti","year":"2016","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.neuropharm.2018.08.017_bib57","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.neuroscience.2015.05.021","article-title":"JWH-018 impairs sensorimotor functions in mice","volume":"300","author":"Ossato","year":"2015","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2018.08.017_bib58","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.pnpbp.2016.01.007","article-title":"Effect of JWH-250, JWH-073 and their interaction on \u201ctetrad\u201d, sensorimotor, neurological and neurochemical responses in mice","volume":"67","author":"Ossato","year":"2016","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2018.08.017_bib59","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1046\/j.1472-8206.2002.00061.x","article-title":"New perspectives in CNS safety pharmacology","volume":"16","author":"Porsolt","year":"2002","journal-title":"Fundam. Clin. Pharmacol."},{"key":"10.1016\/j.neuropharm.2018.08.017_bib60","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.bbr.2009.04.021","article-title":"Prepulse inhibition and genetic mouse models of schizophrenia","volume":"204","author":"Powell","year":"2009","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.neuropharm.2018.08.017_bib61","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0059334","article-title":"The ketamine analogue methoxetamine and 3- and 4-methoxy analogues of phencyclidine are high affinity and selective ligands for the glutamate NMDA receptor","volume":"8","author":"Roth","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.neuropharm.2018.08.017_bib62","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1097\/JCP.0b013e3181612cdc","article-title":"Trapped in the \u2018K-hole'; overview of deaths associated with ketamine misuse in the UK (1993-2006)","volume":"28","author":"Schifano","year":"2008","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.neuropharm.2018.08.017_bib63","first-page":"263","article-title":"Recent advances in the pharmacological management of acute and chronic pain","volume":"3","author":"Schug","year":"2014","journal-title":"Ann. Palliat. Med."},{"key":"10.1016\/j.neuropharm.2018.08.017_bib64","doi-asserted-by":"crossref","first-page":"438","DOI":"10.3109\/15563650.2012.683437","article-title":"Methoxetamine associated reversible cerebellar toxicity: three cases with analytical confirmation","volume":"50","author":"Shields","year":"2012","journal-title":"Clin. Toxicol."},{"key":"10.1016\/j.neuropharm.2018.08.017_bib65","first-page":"171","article-title":"Effects of ketamine on experimental animal models of aggression","volume":"17","author":"Takahashi","year":"1984","journal-title":"Braz. J. Med. Biol. Res."},{"key":"10.1016\/j.neuropharm.2018.08.017_bib66","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1080\/02791072.2017.1333660","article-title":"Beyond ketamine and phencyclidine: analytically confirmed use of multiple novel arylcyclohexylamines","volume":"49","author":"Thornton","year":"2017","journal-title":"J. Psychoact. Drugs"},{"key":"10.1016\/j.neuropharm.2018.08.017_bib67","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/0091-3057(82)90311-2","article-title":"Effects of phencyclidine on aggressive behavior in mice","volume":"17","author":"Tyler","year":"1982","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.neuropharm.2018.08.017_bib68","series-title":"World Drug Report","doi-asserted-by":"crossref","DOI":"10.18356\/c595e10f-en","author":"United Nations Office on Drugs and Crime (UNODC)","year":"2017"},{"key":"10.1016\/j.neuropharm.2018.08.017_bib69","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.neuropharm.2015.02.008","article-title":"Novel halogenated derivates of JWH-018: behavioral and binding studies in mice","volume":"95","author":"Vigolo","year":"2015","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2018.08.017_bib70","doi-asserted-by":"crossref","first-page":"156","DOI":"10.3389\/fpsyt.2017.00156","article-title":"Synthetic cathinone and cannabinoid designer drugs pose a major risk for public health","volume":"8","author":"Weinstein","year":"2017","journal-title":"Front. Psychiatr."},{"key":"10.1016\/j.neuropharm.2018.08.017_bib71","doi-asserted-by":"crossref","first-page":"683","DOI":"10.2478\/s13382-014-0290-8","article-title":"Acute methoxetamine and amphetamine poisoning with fatal outcome: a case report","volume":"27","author":"Wiergowski","year":"2014","journal-title":"Int. J. Occup. Med. Environ. Health"},{"key":"10.1016\/j.neuropharm.2018.08.017_bib72","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1007\/s00228-011-1199-9","article-title":"Acute toxicity associated with the recreational use of the ketamine derivative methoxetamine","volume":"68","author":"Wood","year":"2012","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"10.1016\/j.neuropharm.2018.08.017_bib73","doi-asserted-by":"crossref","DOI":"10.1097\/FBP.0000000000000241","article-title":"Methoxetamine, a novel psychoactive substance with serious adverse pharmacological effects: a review of case reports and preclinical findings","volume":"27","author":"Zanda","year":"2016","journal-title":"Behav. Pharmacol."},{"key":"10.1016\/j.neuropharm.2018.08.017_bib74","doi-asserted-by":"crossref","first-page":"3333","DOI":"10.1111\/bph.13952","article-title":"Methoxetamine affects brain processing involved in emotional response in rats","volume":"174","author":"Zanda","year":"2017","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2018.08.017_bib75","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/j.toxlet.2014.08.011","article-title":"Methoxetamine--a novel recreational drug with potent hallucinogenic properties","volume":"230","author":"Zawilska","year":"2014","journal-title":"Toxicol. Lett."},{"key":"10.1016\/j.neuropharm.2018.08.017_bib76","doi-asserted-by":"crossref","first-page":"110","DOI":"10.3389\/fpsyt.2017.00110","article-title":"An expanding world of novel psychoactive substances: Opioids","volume":"8","author":"Zawilska","year":"2017","journal-title":"Front. Psychiatr."}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002839081830532X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002839081830532X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,7,9]],"date-time":"2024-07-09T17:02:42Z","timestamp":1720544562000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S002839081830532X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10]]},"references-count":74,"alternative-id":["S002839081830532X"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2018.08.017","relation":{},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2018,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Neurological, sensorimotor and cardiorespiratory alterations induced by methoxetamine, ketamine and phencyclidine in mice","name":"articletitle","label":"Article Title"},{"value":"Neuropharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuropharm.2018.08.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}